Endoglucanase mutant with improved pH tolerance and preparation method thereof
By performing site-directed mutation of endoglucanase, the pH tolerance is improved, and the problem of insufficient enzyme activity of existing endoglucanases within a wide pH range is solved, and the range of pH 3.0 to 11.0 is achieved. The efficient catalytic performance, especially the significant improvement under pH 9.0, is suitable for industrial applications of cellulose hydrolysis.
Patent Information
- Application Number
- CN202411305408.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-19
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-09-19
AI Technical Summary
The existing endoglucanase has insufficient enzyme activity in a wide pH range, making it difficult to adapt to complex industrial application environments, especially in areas with complex reaction conditions such as textiles, resulting in low catalytic efficiency.
By artificial site-directed mutation of endoglucanase from Bacillus derived from Bacillus, endoglucanase mutants with mutated amino acid sequences, such as V217L, A123S/I165V and A123G/I165L/V185S/V217C, improving Its pH tolerance enhances enzyme activity under different pH conditions.
The enzyme activity of the mutant in the pH range of 3.0 to 11.0 is significantly improved, especially under pH 9.0, the residual enzyme activity is increased by 66%, providing more stable and efficient catalytic performance and is suitable for industrial applications.
Smart Images

Figure CN118910016A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an endoglucanase mutant, in particular to an endoglucanase mutant with improved pH tolerance, and belongs to the technical field of genetic engineering. Background Art
[0002] Cellulose is the most widely distributed and abundant polysaccharide in nature. It is an environmentally friendly, biodegradable natural organic polymer material. Cellulose and its derivatives are widely used in many fields such as biomedicine, food, electronic components, and new energy. Its hydrolyzate is an important raw material for brewing engineering, production of paper and textiles, biofuels, and chemicals. As the main structural component of plant cell walls, cellulose is usually combined with hemicellulose, pectin, and lignin, so it has a great influence on the texture of plant-based products. For example, in the food processing industry, the presence of cellulose will reduce the extraction rate and quality of juice, and have a negative impact on production efficiency and product quality. Among the various methods of degrading cellulose, the biodegradation method using cellulase has become the focus of attention in industrial production related to cellulose due to its mild reaction conditions and environmental friendliness.
[0003] Endoglucanase is an important cellulase that can randomly cut the amorphous region inside the cellulose polysaccharide chain, hydrolyze glycosidic bonds, break cellulose chains, produce oligosaccharides of different lengths and the ends of new chains, and play an important role in degrading cellulose molecules. According to the different optimal pH, endoglucanases can be divided into acidic endoglucanases, neutral endoglucanases and alkaline endoglucanases, which are suitable for different application scenarios. In the fields of textiles and washing with complex reaction conditions, endoglucanases with higher pH tolerance can adapt to a wider pH environment and provide a more stable and efficient catalytic effect. Chinese invention patent CN 104673713 A discloses an alkaliphilic streptomyces and its produced neutral endoglucanase and application, the enzyme activity of which can be maintained at more than 70% in the range of pH 3 to 9. However, it is currently known that endoglucanases that can maintain high activity in a wide pH range are very limited, so related research is of great significance to industrial production involving cellulose. Summary of the invention
[0004] Purpose of the invention: The purpose of the present invention is to provide an endoglucanase mutant with improved pH tolerance, and to provide a nucleic acid molecule encoding the mutant, a vector or recombinant cell or product comprising the mutant, and a preparation method and application of the mutant.
[0005] Technical solution: The first aspect of the present invention provides three endoglucanase mutants, wherein the amino acid sequence of the endoglucanase mutant is obtained by mutation of the sequence shown in SEQ ID NO.1, and the mutation is V217L or A123S / I165V or A123G / I165L / V185S / V217C.
[0006] The present invention uses endoglucanase from Geobacillus sp. 70PC53 as the original enzyme, whose amino acid sequence is shown in SEQ ID No. 1, and nucleotide sequence is shown in SEQ ID No. 2. The endoglucanase mutant is obtained by artificially performing site-directed mutation on the original enzyme.
[0007] The present invention uses the standard single letter and standard substitution notation of amino acids: V217L means that the valine (V) at the 217th position of the N-terminus is mutated to leucine (L); A123S / I165V means that the alanine (A) at the 123rd position of the N-terminus is mutated to serine (S), and the isoleucine (I) at the 165th position of the N-terminus is mutated to valine (V).
[0008] In a second aspect, the present invention provides a nucleic acid molecule encoding the endoglucanase mutant described in the first aspect. The nucleotide sequence of the nucleic acid molecule is obtained by base mutation of the sequence shown in SEQ ID NO.2.
[0009] In a third aspect, the present invention provides a vector comprising the nucleotide sequence described in the second aspect. The vector may be a cloning vector or an expression vector.
[0010] In a fourth aspect, the present invention provides a recombinant cell, wherein the recombinant cell comprises the vector described in the third aspect.
[0011] In a fifth aspect, the present invention provides a method for preparing the endoglucanase mutant described in the first aspect, comprising the following steps: (1) designing point mutation primers, using a plasmid containing the nucleotide sequence of SEQ ID NO.2 as a template, performing a PCR reaction, digesting the template with an endonuclease, and then recombining the digestion product to obtain an expression vector carrying a mutant gene; (2) transferring the expression vector into a host bacterium for fermentation expression; and (3) collecting the broken cells of the host bacterium, centrifuging and taking the supernatant to obtain the endoglucanase mutant.
[0012] In a sixth aspect, the present invention provides a product, comprising the endoglucanase mutant described in the first aspect, or the nucleic acid molecule described in the second aspect, or the vector described in the third aspect, or the recombinant cell described in the fourth aspect.
[0013] In a seventh aspect, the present invention provides a use of the product of the sixth aspect in catalyzing cellulose hydrolysis, wherein the pH condition of the catalysis is 3.0-11.0.
[0014] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: 1. The pH tolerance of the endoglucanase mutant provided by the present invention is better than that of the original enzyme. Under the condition of pH 9.0, the residual enzyme activity of the mutant can be increased by 66% compared with the original enzyme; 2. The relative enzyme activity of the endoglucanase mutant provided by the present invention in the range of pH 3.0 to 11.0 is higher than that of the original enzyme, and it can maintain stable and efficient catalytic performance under such conditions, and has good industrial application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 The schematic diagram of the protein structure of the original enzyme of the present invention (including amino acid positions No. 217 and No. 185);
[0016] Figure 2 The schematic diagram of the protein structure of the original enzyme of the present invention (including amino acid positions No. 123 and No. 165);
[0017] Figure 3 Schematic diagram of the relative enzyme activities of the original enzyme and mutants under different pH conditions. DETAILED DESCRIPTION
[0018] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.
[0019] Unless otherwise specified, the materials and reagents used in the examples can be obtained from commercial sources.
[0020] Example 1 Endoglucanase mutant V217L
[0021] In this example, Geobacillus sp. 70PC53 endoglucanase was used as the original enzyme, and the valine (V) at position 217 of the N-terminal amino acid sequence shown in SEQ ID No. 1 was mutated to leucine (L). The structure of the original enzyme is shown in Figure 1 As shown, the nucleic acid sequence is shown as SEQ ID No.2.
[0022] The preparation method of the mutant V217L is as follows: 1. constructing a recombinant plasmid; 2. expressing the enzyme mutant and preparing a crude enzyme solution.
[0023] The details are as follows:
[0024] 1. Construction of recombinant plasmid
[0025] Plasmid pET-22b(+) and E. coli DH5α were both commercially available and deposited by the applicant. The original enzyme was synthesized by Genwi (Suzhou) Co., Ltd. and inserted between the NdeI and XhoI restriction sites of plasmid pET-22b(+). 3D modeling was performed using PyMOL to determine that amino acid 217 was the mutation site. The position of this amino acid in the protein is as follows: Figure 1 Using the plasmid with the original enzyme as a template, site-directed mutagenesis was performed by PCR. The mutation primers are shown in Table 1, the PCR system is prepared as shown in Table 2, and the PCR program is set as shown in Table 3.
[0026] Table 1 Primers for mutant V217L
[0027] Mutation primer name Sequence (5'-3') V217L-F CGATCGCCTGGATGCGGCGCTGCAAGCGGGC V217L-R CGCATCCAGGCGATCGCGCAGCCACTGCGTATG
[0028] Note: The underlined part in the primers indicates the mutation site, “F” represents the upstream primer and “R” represents the downstream primer.
[0029] Table 2 PCR reaction system
[0030] Composition volume 10×BufferforKOD-Plus- 2.5μL 2mM dNTP 2.5μL <![CDATA[25mMMgSO 4 ]]> 1.5μL DMSO 1μL 10pmol / μLForwardPrimer 0.75μL 10pmol / μLReversePrimer 0.75μL DNA template <100ng KOD-Plus- 1μL <![CDATA[ddH 2 The]]> up to 25 μL
[0031] Table 3 PCR reaction program
[0032]
[0033] 1 μL DpnI restriction endonuclease was added to the PCR product and digested at 37°C for 1 h.
[0034] 2. Construction of strains expressing recombinant mutant enzymes and preparation of crude enzyme solution
[0035] The above digestion products were transformed into E.coli DH5α competent cells by heat shock method, cultured at 37℃ for 1 hour, spread on LB solid medium containing 100μg / mL ampicillin, and cultured at 37℃ overnight. Select a single colony and inoculate it into LB liquid medium containing 100μg / mL ampicillin for overnight culture. Use the Sangon Plasmid Extraction Kit to extract the plasmid and send it to Jinweizhi (Suzhou) for sequencing. The plasmid with the correct mutant enzyme body was heat-shocked and transformed into E.coli BL21 competent cells, spread on LB solid medium containing 100μg / mL ampicillin, and cultured at 37℃ overnight. Select a single colony and inoculate it into LB liquid medium containing 100μg / mL ampicillin for overnight culture. Add 50% glycerol to the culture medium of the recombinant strain and store it at -80℃.
[0036] Pick the bacterial liquid from the glycerol bacteria and streak it on LB solid medium containing 100μg / mL ampicillin, and culture it at 37℃ overnight. Inoculate a single colony into 3mL LB liquid medium containing 100μg / mL ampicillin, and culture it at 37℃ for 8h. According to the 5% inoculation amount, it is transferred to a 250mL conical flask containing 50mL TB medium (yeast powder 12g / L, tryptone 12g / L, glycerol 4ml / L, dipotassium hydrogen phosphate 12.5g / L, potassium dihydrogen phosphate 2.3g / L), and cultured at 37℃ and 180rpm. After culturing for 8h, add 50μL 400mM IPTG solution and continue to culture at 22℃ for 22h. Collect the fermentation broth, centrifuge at 8000g for 20min, and collect the bacteria. Wash the cells twice with 200mM, pH7.0 PBS buffer, and finally resuspend the cells in 10mL of the corresponding pH buffer. The cells were disrupted by ultrasound for 5 minutes, and ultrasound was turned off for 5 seconds every 5 seconds. The mixture was centrifuged at 8000 g for 20 minutes, and the supernatant was collected as the crude enzyme solution of endoglucanase mutant V217L.
[0037] Example 2 Endoglucanase mutant A123S / I165V
[0038] In this example, the alanine (A) at the 123rd position of the N-terminal end of the original endoglucanase sequence shown in SEQ ID No. 1 is mutated to serine (S), and the isoleucine (I) at the 165th position is mutated to valine (V). The position of the amino acid in the protein is as shown in Figure 2 The mutation primers are shown in Table 4. The preparation method is as shown in Example 1.
[0039] Table 4 Primers for mutant A123S / I165V
[0040] Mutation primer name Sequence (5'-3') A123S-F CTTTTTTAGCGAAATGGCGCGCGAATATGGC A123S-R CCATTTCGCTAAAAAAGCGTTTCGCTTGTTC I165V-F CGCACCGTGCGCAGCATTGATCGCGATAAC I165V-R GCTGCGCACGGTGCGAATCACTTCATCCGC
[0041] Example 3 Endoglucanase mutant A123G / I165L / V185S / V217C
[0042] In this example, the alanine (A) at the 123rd position of the N-terminal end of the original enzyme sequence of endoglucanase as shown in SEQ ID No. 1 is mutated to glycine (G), and the isoleucine (I) at the 165th position is mutated to leucine (L), the valine (V) at the 185th position is mutated to serine (S), and the valine (V) at the 217th position is mutated to cysteine (C). The positions of the amino acids in the protein are as follows: Figure 1 and Figure 2 The primers are shown in Table 5. The preparation method is as shown in Example 1.
[0043] Table 5 Primers for mutant A123G / I165L / V185S / V217C
[0044] Mutation primer name Sequence (5'-3') A123G-F CTTTTTGGCGAAATGGCGCGCGAATATGGC A123G-R CCATTTCGCCAAAAAAGCGTTTCGCTTGTTC I165L-F CGCACCCTGCGCAGCATTGATCGCGATAAC I165L-R GCTGCGCAGGGTGCGAATCACTTCATCCGC V185S-F CCAAGATAGCGATGATGTGGCGAGCGATCCG V185S-R CATCATCGCTATCTTGGCTCCAGGTGCCGGT V217C-F CGATCGCTGCGATGCGGCGCTGCAAGCGGGC V217C-R CGCATCGCAGCGATCGCGCAGCCACTGCGTATG
[0045] Example 4 Determination of the enzyme activity of the original endoglucanase and its mutants under different pH conditions
[0046] Disodium hydrogen phosphate-citrate buffer with pH values of 3.0 and 5.0 and Tris buffer with pH values of 7.0, 9.0 and 11.0 were prepared respectively, and the cells in Examples 1 to 3 were resuspended. The cells were ultrasonically disrupted as described in Example 1 and the crude enzyme solution was collected.
[0047] 1% sodium carboxymethyl cellulose solution was used as the substrate for the enzymatic reaction, and the enzyme activity was determined by the dinitrosalicylic acid method. The specific method was as follows: 30 μL crude enzyme solution and 120 μL 1% sodium carboxymethyl cellulose solution were added to a clean ELISA plate, and the reaction was carried out at 60°C for 30 minutes. 150 μL DNS solution was added to stop the reaction and the reaction was placed in a boiling water bath for 10 minutes. The reaction was quickly cooled to room temperature and the absorbance was measured at 540 nm. The sample to which the inactivated enzyme solution was added under the same conditions was used as a blank control. The enzyme activity (U) of endoglucanase is defined as: under the above reaction and analysis conditions, the amount of enzyme that catalyzes the reduction power of 1 μmoL glucose per minute is defined as one enzyme activity unit. The enzyme activity of the original enzyme at pH 7.0 is defined as 100%, and the relative enzyme activity is calculated by comparing it with the activity of the remaining enzymes to investigate the optimal pH of the enzyme.
[0048] Test results such as Figure 3 As shown. The results showed that the enzymatic activity of the original endoglucanase was affected under both acidic and alkaline conditions. At pH 3.0 and pH 11.0, the residual enzyme activity was only 46.7% and 49.0% of that at pH 7.0, showing low pH tolerance. The pH tolerance of the enzyme mutants V217L, A123S / I165V and A123G / I165L / V185S / V217C was improved. At pH 5.0, the residual enzyme activity of the enzyme mutant A123S / I165V was increased by 50.3% compared with the original enzyme; at pH 9.0, the residual enzyme activity of the enzyme mutants A123S / I165V and V217L was increased by 57.8% and 66.0%, respectively, compared with the original enzyme.
Claims
1. An endoglucanase mutant, characterized in that The amino acid sequence of the endoglucanase mutant is obtained by mutation of the sequence shown in SEQ ID NO.1, wherein the mutation is V217L or A123S / I165V or A123G / I165L / V185S / V217C.
2. A nucleic acid molecule, characterized in that The nucleic acid molecule encodes the endoglucanase mutant according to claim 1.
3. The nucleic acid molecule according to claim 2, characterized in that The nucleotide sequence of the nucleic acid molecule is obtained by base mutation of the sequence shown in SEQ ID NO.
2.
4. A carrier, characterized in that Comprising the nucleotide sequence of claim 3.
5. The carrier according to claim 4, characterized in that The vector is a cloning vector or an expression vector.
6. A recombinant cell, characterized in that The recombinant cell comprises the vector of claim 4.
7. A method for preparing the endoglucanase mutant according to claim 1, characterized in that: The following steps are involved: (1) Designing point mutation primers, using a plasmid containing the nucleotide sequence of SEQ ID NO.2 as a template, performing a PCR reaction, digesting the template with an endonuclease, and then recombining the digestion product to obtain an expression vector carrying a mutant gene; (2) Transforming the expression vector into a host bacterium for fermentation expression; (3) Collecting the host bacterium, disrupting the cells, and centrifuging to obtain the supernatant to obtain the endoglucanase mutant.
8. A product, characterized in that The product comprises the endoglucanase mutant according to claim 1 or the nucleic acid molecule according to any one of claims 2 to 3 or the vector according to claim 4 or the recombinant cell according to claim 6.
9. Use of the product according to claim 8 in catalyzing cellulose hydrolysis.
10. The use according to claim 9, characterized in that: The catalytic pH condition is 3.0-11.0.
Citation Information
Patent Citations
Low-temperature beta-1, 4-endoglucanase and alkali-resistant enzyme mutant
CN116497006A
Endo-beta-1, 4-glucanase mutant as well as gene, carrier and preparation method thereof
CN118165960A
Novel Thermophilic Endo-Glucanase and Uses Thereof
US20100047869A1
Cited By
Glucose dehydrogenase mutant with high pH tolerance and application thereof
CN118995650A
High pH-tolerant glucose dehydrogenase mutant and its application
CN118995650B
Acidic endoglucanase variants and uses thereof
CN120843483A
